Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer [Phase 1]
Phase 1 trial evaluating adding ipatasertib to paclitaxel and carboplatin for Stage III/IV ovarian, fallopian tube, and primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer [Phase 1]
Phase 1 study evaluating carboplatin and paclitaxel chemotherapy with nivolumab, with or without ipilimumab, in ovarian cancer including hig…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment
This completed feasibility trial evaluated saliva-based and remote monitoring approaches for detecting active cytomegalovirus infection and …
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients [Phase 3]
Phase 3 trial evaluating prevention and treatment of chemotherapy-induced nausea and vomiting in gynecologic cancer patients treated with th…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating REGN5668 with cemiplimab, cemiplimab plus fianlimab, or ubamatamab in adult women with ovarian cancer,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer [Phase 2]
Phase 2 trial comparing MV-NIS versus investigator's choice chemotherapy in patients with ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Trial Evaluating TG4050 in Ovarian Carcinoma. [Phase 1]
Phase 1 trial evaluating TG4050 for ovarian cancer (including fallopian tube and peritoneal cancers) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [EARLY_Phase 1]
This clinical trial update reports the completion of an early-phase Phase 1 vaccine therapy trial for patients with Stage IIIC-IV ovarian ep…
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study of stereotactic body radiation therapy for recurrent primary ovarian or uterine cancer…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating quality of life after hyperthermic intraperitoneal chemotherapy in advanced ovarian, fallopian tube, and primary pe…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer [Phase 1]
Phase 1 study evaluating STRO-002 in combination with bevacizumab for epithelial ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluating the combination of durvalumab and tremelimumab in participants with recurrent or treatment-refractory ovarian, fa…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Nudge to Gynecologic Oncology [NA]
A clinical trial update indicating the gynecologic oncology study is currently active but not recruiting, with conditions including ovarian …
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) [Phase 3]
A Phase 3 trial evaluating pembrolizumab followed by maintenance olaparib with first-line chemotherapy in BRCA non-mutated advanced epitheli…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy
A completed clinical trial in gynecologic cancers evaluated taste alteration, sarcopenia, and malnutrition in patients treated with carbopla…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) [Phase 3]
A Phase 3 study assessing nemvaleukin alfa in combination with pembrolizumab for platinum-resistant ovarian cancer has been terminated. Resu…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating outcomes after secondary cytoreductive surgery with or without carboplatin-based HIPEC, followed by systemic chemot…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers [Phase 1]
This clinical trial update summarizes the Phase 1 study of STRO-002, an anti-Folate Receptor Alpha antibody-drug conjugate, in ovarian and e…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial of FT538 for recurrent ovarian, fallopian tube, and primary peritoneal cancer has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a T-cell therapy in combination with nivolumab, relatlimab, and ipilimumab in metastatic ovarian cancer and rel…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients [NA]
A Mayo Clinic–sponsored clinical trial evaluating prehabilitation for patients with advanced ovarian, fallopian tube, or primary peritoneal …
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating MV-NIS infected mesenchymal stem cells for recurrent ovarian, primary peritoneal, or fallopian tube cancer. Res…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial comparing MORAb-202 to investigator's choice chemotherapy in women with platinum-resistant high-grade serous ovarian cancer an…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial update describing a study on personalized timing of interval debulking surgery for advanced ovarian cancer; recruitment is ong…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Biomarker Screening Protocol for Participants With Solid Tumors
A clinical trial update describes a biomarker screening protocol for participants with solid tumors, and the study has been terminated.